ASNC invites individuals to submit an abstract of original investigation for review and consideration for presentation at the 15th Annual Scientific Session of the American Society of Nuclear Cardiology, September 23 – 26, 2010 in Philadelphia.

• ASNC2010 Accepted Abstracts (PDF)
  Browse abstracts scheduled for presentation at ASNC2010.
• Abstract Embargo Policy (PDF)

Important Dates and Deadlines

February 1, 2010	Abstract Submission Site Opens
March 29, 2010	Abstract Submission Site Closes
April 15, 2010	Notification to Presenting Authors of Acceptance Status
April 19, 2010	Deadline to Withdraw Abstracts from Consideration
May 1, 2010	Late-Breaking Clinical Trial Abstract Submission Site Opens
June 16, 2010	Late-Breaking Clinical Trial Abstract Submission Site Closes
July 2010	Publication of Accepted Abstracts in July/August Issue of the Journal of Nuclear Cardiology (Print and Online)
July 2, 2010	Notification to Late-Breaking Clinical Trial Abstract Authors of Acceptance Status
July 30, 2010	Young Investigator Registration Forms Due
September 23 – 26, 2010	Presentation of Accepted Abstracts at ASNC2010

Submission Categories

Two abstract categories are available for ASNC2010:

1. Original Scientific Abstracts: Accepted abstracts will be programmed as poster presentations (abstracts accepted for the Young Investigator Competition will be presented orally) and will be published in the Journal of Nuclear Cardiology.
   
   
2. Original Abstracts of Late-Breaking Clinical Trials: Accepted abstracts in this category will be programmed as oral presentations and will not be published in the Journal of Nuclear Cardiology.  These trials are expected to be large or multi-center prospective trials of major clinical import, involving generally more than 500 patients.  For these abstracts, the submission deadline is later to allow for analysis of data closer to ASNC2010.

Authors need not be ASNC members to submit an abstract.  Submission is free of charge and presenting authors are eligible for a reduced registration fee to attend the meeting.  Please review the Abstract Submission Guidelines before submitting your work.

Abstract submissions will be condered for oral or poster presentation on the following topics:

• Acute ischemic syndrome (including MI and unstable angina)
• Appropriateness criteria
• Assessment of cost-effectiveness
• Comparative effectiveness
• Comparison to other methods (eg, 2DE, MRI)
• Computed tomography
• Congestive heart failure, arrhythmias, and sudden death
• Diagnosis: ECG and perfusion markers of ischemia with exercise and/or pharmacologic stress
• Experimental nuclear cardiology/molecular biology
• Half-time, quarter-time, or ultra-fast SPECT
• Instrumentation
• Kinetics and radiochemistry
• Myocardial blood flow, coronary angiography, collaterals
• Myocardial infarction: Diagnosis and risk assessment
• Myocardial viability
• New tracers, new drugs, and interventional methods
• New software
• New hardware
• New protocols
• Non-PET metabolic imaging
• Perfusion imaging methods and protocols
• PET
• PET-metabolic imaging
• Risk assessment after PTCA, CABG
• Risk assessment before non-cardiac surgery
• Risk assessment in stable patients
• RNA (gated, first-pass) for LV and RV
• Solid state detectors
• Other (mental stress, cardiotoxicity, congenital heart idsease, transplant, microvascular disease, silent ischemia, etc.)

Additional Resources

• Young Investigator Award Competition

Please direct questions to Meridith Phillips at ASNC2010@asnc.org.